Yong Yang Selected Research

Formaldehyde (Formol)

06/2008	[Periaqueductal gray administration of HSV-I amplicon vector-mediated HPPE gene therapy of nocicepion in rats with formalin-induced pain.]
10/2006	[Intrathecal administration of HSV-I amplicon vector-mediated HPPE gene therapy of nocicepion in rats with formalin pain]
10/2006	[Effect of intrathecal katemine on the expression of nNOS in spinal dorsal horn in rats with formalin pain]

Articles by Research Topic

Disease

7	Hepatocellular Carcinoma (Hepatoma) 10/2007 - 10/2003
4	Carcinoma (Carcinomatosis) 07/2008 - 03/2007
3	Neoplasms (Cancer) 11/2008 - 02/2003
3	Pain (Aches) 06/2008 - 10/2006
2	Leukemia 09/2008 - 04/2008
2	Breast Neoplasms (Breast Cancer) 08/2008 - 12/2006
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2008 - 03/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008 - 12/2007
2	Brain Ischemia (Cerebral Ischemia) 01/2008 - 06/2006
2	Urethral Stricture 12/2007 - 06/2007
2	Glioma (Gliomas) 12/2005 - 11/2005
1	Tissue Adhesions 07/2008
1	Melanoma (Melanoma, Malignant) 07/2008
1	Acute Coronary Syndrome 06/2008
1	Glioblastoma (Glioblastoma Multiforme) 03/2008
1	Urinary Retention 03/2008
1	Wounds and Injuries (Trauma) 12/2007
1	Vaginal Fistula 06/2007
1	Erythromelalgia (Erythermalgia) 01/2007
1	Erectile Dysfunction 12/2006
1	Sarcoma (Soft Tissue Sarcoma) 06/2006
1	Parkinson Disease (Parkinson's Disease) 06/2005
1	Burns 02/2005
1	Cicatrix (Scar) 02/2005
1	Colorectal Neoplasms (Colorectal Cancer) 05/2004
1	Xeroderma Pigmentosum (Kaposi's Disease) 08/2003
1	Necrosis 04/2002
1	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2002

Drug/Important Bio-Agent (IBA)

7	gambogic acidIBA 11/2008 - 03/2007
5	wogoninIBA 09/2008 - 06/2006
3	Formaldehyde (Formol)IBA 06/2008 - 10/2006
3	CD29 AntigensIBA 10/2007 - 01/2007
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 08/2008 - 02/2005
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 06/2008
1	Cadherins (E-Cadherin)IBA 05/2008
1	Tyrosine (L-Tyrosine)FDA Link 04/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2008
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2008
1	Phospholipid Transfer ProteinsIBA 04/2008
1	connexin 37IBA 01/2008
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2008
1	Histones (Histone)IBA 06/2007
1	terazosine (terazosin)FDA LinkGeneric 03/2007
1	Sodium Channels (Sodium Channel)IBA 01/2007
1	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 01/2007
1	Small Interfering RNA (siRNA)IBA 12/2006
1	oroxylin AIBA 12/2006
1	aildenafilIBA 12/2006
1	Citric Acid (Citrate)FDA LinkGeneric 12/2006
1	Potassium Channels (Potassium Channel)IBA 06/2006
1	Adenosine Triphosphate (ATP)IBA 06/2006
1	N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA 06/2006
1	Epidermal Growth Factor Receptor (EGF Receptor)IBA 12/2005
1	Nerve Growth Factor (NGF)IBA 11/2005
1	KATP ChannelsIBA 06/2005
1	Haloperidol (Haldol)FDA LinkGeneric 06/2005
1	Oxidopamine (6 Hydroxydopamine)IBA 06/2005
1	Messenger RNA (mRNA)IBA 02/2005
1	AntigensIBA 05/2004
1	Antisense RNA (Anti-Sense RNA)IBA 10/2003
1	Complementary DNA (cDNA)IBA 08/2003
1	IodineIBA 02/2003
1	Collagen Type VIIIBA 01/2002

Therapy/Procedure

1	Lasers (Laser) 03/2008
1	Prostatectomy (Retropubic Prostatectomy) 03/2008
1	Laser Therapy (Surgery, Laser) 03/2008
1	Extracorporeal Membrane Oxygenation (ECMO) 12/2007
1	Stents 12/2007
1	Homologous Transplantation (Allograft) 06/2007
1	Brachytherapy 02/2003
1	Kidney Transplantation 04/2002